Catatan efek · kuartal yang diarsipkan
ACRS
Aclaris Therapeutics, Inc. · Healthcare · Biotechnology
17Pemegang yang dilacak
+1Δ pemegang
36.82MSaham yang dipegang
$69.96MNilai yang dilaporkan
+1Posisi baru
−0Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang +6.2% ·
aliran saham -17.7% ·
posisi baru bersih +5.9%
— formula
Fragmentasi kepemilikan — lebih banyak pemegang, agregat kepemilikan lebih kecil
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | -2 | 42.13M | $222.66M | +3 | −5 |
| Q1 2026 | 65 | -2 | 41.75M | $156.42M | +5 | −7 |
| Q4 2025 | 67 | +2 | 40.44M | $121.72M | +2 | — |
| Q3 2025 | 17 | +1 | 36.82M | $69.96M | +1 | — |
| Q2 2025 | 13 | 0 | 38.17M | $54.21M | — | — |
| Q1 2025 | 10 | 0 | 23.63M | $36.15M | — | — |
| Q4 2024 | 10 | +2 | 20.49M | $50.82M | +2 | — |
| Q3 2024 | 7 | -1 | 10.01M | $11.51M | — | −1 |
| Q2 2024 | 8 | — | 10.87M | $11.95M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 6.52M | -2.2% | $12.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 6.52M | -2.2% | $12.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 6.52M | -2.2% | $12.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 5.69M | +3.2% | $10.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 5.28M | -45.2% | $10.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 4.08M | — | $7.75M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasif) | 2.39M | -3.0% | $4.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasif) | 2.39M | -3.0% | $4.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 2.37M | -15.2% | $4.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 2.37M | -15.2% | $4.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Marshall Wace ✦ | 1.72M | -25.1% | $3.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Marshall Wace ✦ | 1.72M | -25.1% | $3.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 1.62M | +10.6% | $3.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Millennium Management ✦ | 1.55M | -59.5% | $2.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.52M | — | $2.88M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.52M | — | $2.88M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 1.52M | — | $2.88M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 1.52M | — | $2.88M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 1.43M | +25.3% | $2.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 1.43M | +25.3% | $2.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | State Street Global Advisors ✦ (pasif) | 1.11M | +10.6% | $2.11M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 956.05K | — | $1.82M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 956.05K | — | $1.82M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 956.05K | — | $1.82M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 368.11K | -50.9% | $699,403 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 140.17K | -15.8% | $267,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 40.35K | -90.9% | $76,665 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 40.35K | -90.9% | $76,665 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 34.95K | Baru | $66,409 | 0.0% | New | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 34.95K | Baru | $66,409 | 0.0% | New | 1 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 34.95K | Baru | $66,409 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| AQR Capital Management | $66,409 | 0.0% |
| AQR Capital Management | $66,409 | 0.0% |
| AQR Capital Management | $66,409 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 135 pemegang, 108.23M saham, $397.63M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API